bell
The current prices are delayed by 15 mins, login to check live prices.
Gufic BioSciences Ltd share price logo

Gufic BioSciences Ltd

(GUFICBIO)

₹410.70.81%

as on 04:01PM, 02 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Gufic BioSciences Ltd Performance

  • Day's Low

    Day's High

    ₹408.95
    ₹417.75
  • 52 Week's Low

    52 Week's High

    ₹277.65
    ₹504.25
1 Month Return-11.04 %
3 Month Return+ 2.95 %
1 Year Return+ 24.73 %
Previous Close₹414.05
Open₹414.05
Volume69.05K
Upper Circuit-
Lower Circuit-
Market Cap₹4,151.99Cr

Gufic BioSciences Ltd Key Statistics

P/E Ratio48.83
PEG Ratio12.33
Market Cap₹4,151.99 Cr
P/B Ratio0
EPS0
Dividend Yield0.04
SectorPharmaceuticals
ROE19.57

Gufic BioSciences Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹4,151.99 Cr101.24%0.70₹86 Cr₹806 Cr
NA₹633.91 Cr412.17%0.54₹23 Cr₹164 Cr
NA₹146.51 Cr49.47%0.57NANA
NA₹1,048.70 Cr112.94%0.53₹50 Cr₹614 Cr
NA₹113.17 Cr10.94%0.57NANA

About Gufic BioSciences Ltd

Gufic Biosciences (GBL) was established as a result of a reverse merger of itself and Central Finance at Rs 4042 per share, allowing for the company to be listed on the Bombay Stock Exchange. The Choksi and Gandhi family, the promoters of GBL, have a long-standing background in the pharmaceutical industry, having formed the joint venture company, Lyka Labs, in 1960. Gufic Biosciences, known as Gujarat Fine Chemicals, first operated in the bulk drug space, before moving into the formulation market. GBL currently offers ethical, herbal, consumer, and bulk drugs, both domestically and internationally, and have a history of creating leading brands. In 2000, GBL issued bonus equity shares at 5:2, and more recently the company has divested some of its assets in the ethical pharma business, with plans to reinvest in R&D activities, and to further invigorate the potential of the herbal and consumer product segments. With traditional knowledge in India, Gufic will be operating from a position of strength around those specific areas.

Share Price: ₹410.70 per share as on 02 Dec, 2024 04:01 PM
Market Capitalisation: ₹4,151.99Cr as of today
Revenue: ₹204.18Cr as on September 2024 (Q3 24)
Net Profit: ₹21.77Cr as on September 2024 (Q3 24)
Listing date: 19 Oct, 2004
Chairperson Name: Jayesh P Choksi
OrganisationGufic BioSciences Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Gufic BioSciences Ltd

  • Gufic Bio Reports Decline in Q3 Financials - 26 Nov, 2024

    Gufic Bio's standalone net sales for September 2024 fell 4.98% to Rs 204.18 crore. Net profit decreased by 6.18% to Rs 21.78 crore, while EBITDA also declined. Despite these drops, shares have shown significant returns over the past year.
  • Gufic Biosciences Reports Decline in Q2 Profit - 18 Nov, 2024

    Gufic Biosciences' Q2 FY25 net profit fell 6.03% YoY to Rs 21.8 crore, with revenue down 4.98%. Despite a decrease in total expenses, the stock tumbled 5.87%. EBITDA also declined by 2.52%.
  • Gufic Biosciences Reports Decline in Q2 Profit - 15 Nov, 2024

    Gufic Biosciences reported a 6% year-on-year drop in Q2 net profit to Rs 21.8 crore, alongside a 4.98% decline in revenue. Despite a decrease in total expenses, EBITDA fell by 2.52%, though the EBITDA margin improved slightly.

Insights on Gufic BioSciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.30% to 2.51% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.23% to 0.24% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.5% return, outperforming this stock by 37.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.51% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 132.4% return, outperforming this stock by 16.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, GUFICBIO stock has moved down by -11.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 24.88% to 24.74% in Sep 2024 quarter

Gufic BioSciences Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹214.87Cr (-)₹201.78Cr (↓6.09%)₹194.99Cr (↓3.37%)₹202.81Cr (↑4.01%)₹204.18Cr (↑0.68%)
Net Income₹23.21Cr (-)₹22.26Cr (↓4.09%)₹20.05Cr (↓9.93%)₹20.86Cr (↑4.04%)₹21.77Cr (↑4.36%)
Net Profit Margin10.80% (-)11.03% (↑2.13%)10.28% (↓6.80%)10.29% (↑0.10%)10.66% (↑3.60%)
Value in ₹ crore
Details2021202220232024
Total Assets₹394.75Cr (-)₹524.98Cr (↑32.99%)₹864.10Cr (↑64.60%)₹1,097.47Cr (↑27.01%)
Total Liabilities₹221.32Cr (-)₹255.87Cr (↑15.61%)₹516.30Cr (↑101.78%)₹564.91Cr (↑9.42%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow- (-)- (-)- (-)- (-)- (-)

Index Inclusions

BSE Healthcare

₹44,195.99

1.21 (530.48%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹55,662.71

0.84 (462.85%)

Gufic BioSciences Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
72.51%
0.00
Foreign Institutions
0.24%
2.75
Mutual Funds
2.51%
9.23
Retail Investors
24.74%
-0.54
Others
0%
-98.82

Gufic BioSciences Ltd Key Indicators

Details20202021202220232024
Return On Equity %22.1729.2243.3125.8419.57

Gufic BioSciences Ltd Valuation

Gufic BioSciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

March 28, 2024

Today (48.83x)

November 29, 2024

Industry (55.31x)

November 29, 2024

Highest (57.25x)

November 8, 2024

LowHigh

Gufic BioSciences Ltd Earnings and Dividends

  • Gufic BioSciences Ltd Earnings Results

    Gufic BioSciences Ltd’s net profit fell -6.2% since last year same period to ₹21.77Cr in the Q2 2024-2025. On a quarterly growth basis, Gufic BioSciences Ltd has generated 4.36% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Gufic BioSciences Ltd Dividends May,2024

    In the quarter ending March 2024, Gufic BioSciences Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.05%.

    Read More about Dividends

Gufic BioSciences Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Gufic BioSciences Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Gufic BioSciences Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Gufic BioSciences Ltd shares.

Gufic BioSciences Ltd (GUFICBIO) share price today is ₹410.7

Gufic BioSciences Ltd is listed on NSE

Gufic BioSciences Ltd is listed on BSE

  • Today’s highest price of Gufic BioSciences Ltd is ₹417.75.
  • Today’s lowest price of Gufic BioSciences Ltd is ₹408.95.

PE Ratio of Gufic BioSciences Ltd is 48.83

PE ratio = Gufic BioSciences Ltd Market price per share / Gufic BioSciences Ltd Earnings per share

Today’s traded volume of Gufic BioSciences Ltd(GUFICBIO) is 69.05K.

Today’s market capitalisation of Gufic BioSciences Ltd(GUFICBIO) is ₹4151.99Cr.

Gufic BioSciences Ltd(GUFICBIOPrice
52 Week High
₹504.25
52 Week Low
₹277.65

Gufic BioSciences Ltd(GUFICBIO) share price is ₹410.7. It is down -18.55% from its 52 Week High price of ₹504.25

Gufic BioSciences Ltd(GUFICBIO) share price is ₹410.7. It is up 47.92% from its 52 Week Low price of ₹277.65

Gufic BioSciences Ltd(GUFICBIOReturns
1 Day Returns
-3.35%
1 Month Returns
-11.04%
3 Month Returns
2.95%
1 Year Returns
24.73%